CRGX

SEC Form 15-12G filed by CARGO Therapeutics Inc.

SEC Form EFFECT filed by CARGO Therapeutics Inc.

SEC Form EFFECT filed by CARGO Therapeutics Inc.

Amendment: SEC Form SCHEDULE 13D/A filed by CARGO Therapeutics Inc.

SEC Form POS AM filed by CARGO Therapeutics Inc.

SEC Form POS AM filed by CARGO Therapeutics Inc.

SEC Form AW filed by CARGO Therapeutics Inc.

SEC Form AW filed by CARGO Therapeutics Inc.

SEC Form 4 filed by Director Dhingra Kapil

SEC Form 25-NSE filed by CARGO Therapeutics Inc.

SEC Form 4 filed by Director Viswanadhan Krishnan

SEC Form 4 filed by Director Lubner David Charles

SEC Form 4 filed by Director Orwin John A

SEC Form 4 filed by Director Henderson Jane

SEC Form 4 filed by Director Bassan Abraham

SEC Form 4 filed by Director Huber Reid M

Officer Radhakrishnan Anup returned $277,786 worth of shares to the company (63,436 units at $4.38), closing all direct ownership in the company (SEC Form 4)

SEC Form S-8 POS filed by CARGO Therapeutics Inc.

SEC Form S-8 POS filed by CARGO Therapeutics Inc.

SEC Form S-8 POS filed by CARGO Therapeutics Inc.

Amendment: SEC Form S-3/A filed by CARGO Therapeutics Inc.

Amendment: SEC Form S-3/A filed by CARGO Therapeutics Inc.

CARGO Therapeutics Inc. filed SEC Form 8-K: Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control of Registrant

Amendment: SEC Form SC 14D9/A filed by CARGO Therapeutics Inc.

Amendment: SEC Form SCHEDULE 13G/A filed by CARGO Therapeutics Inc.